GlassScriptPhysician profile
Dennis Patrick Mcgowan
NPI 1598855298
$10,823.73
in general payments reported to CMS, 2019-2025
33 companies · $1,601 in 2025
The $1,601 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,132 · 2020: $823 · 2021: $1,198 · 2022: $835 · 2023: $3,605 · 2024: $631 · 2025: $1,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,151 · Food and Beverage: $2,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,151.18 |
| Food and Beverage | $2,685.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,183.97 | 2023-2025 | Na |
| Osteonovus, INC. | $1,522.45 | 2019 | |
| Centinel Spine, LLC | $1,196.35 | 2019-2021 | |
| Orthofix Medical, INC. | $902.00 | 2019-2020 | |
| Curvafix, INC. | $822.09 | 2023-2025 | Curvafix Im Implant |
| Depuy Synthes Sales INC. | $687.15 | 2021-2025 | Na, Tfn-Advance, Lcp |
| Musculoskeletal Transplant Foundation INC. | $456.21 | 2022 | |
| Innovation Technologies INC | $257.82 | 2025 | Irrisept |
| Integra Lifesciences Corporation | $197.07 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cerapedics INC. | $160.52 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Ulrich Medical USA, INC. | $133.02 | 2021-2022 | |
| Kerecis Limited | $128.98 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Choice Spine, LLC | $124.71 | 2021 | |
| Kyocera Medical Technologies, INC. | $113.37 | 2022 | |
| Spinal Balance INC | $104.07 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $101.49 | 2024 | |
| Irhythm Technologies, INC. | $99.46 | 2024 | Zio Monitor, Zio Xt Patch |
| Vertex Pharmaceuticals Incorporated | $79.79 | 2025 | |
| Innovasis INC | $75.48 | 2021 | |
| Sanara Medtech INC. | $65.09 | 2022 | |
| Spineology INC. | $60.57 | 2020 | |
| Integrity Implants INC. | $58.30 | 2022 | |
| Radius Health, INC. | $42.21 | 2023-2025 | Tymlos |
| Si-Bone, INC. | $40.24 | 2020-2023 | |
| Polynovo North America LLC | $37.67 | 2023 | |
| Stryker Corporation | $35.60 | 2019 | |
| Zimmer Biomet Holdings, INC. | $30.55 | 2025 | Persona |
| Heron Therapeutics, INC. | $29.00 | 2022 | |
| Linvatec Corporation | $23.47 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.57 | 2023 | Seglentis |
| E.R. Squibb & Sons, L.L.C. | $13.92 | 2025 | Camzyos |
| Smith+Nephew, INC. | $12.66 | 2022 | |
| Lifenet Health | $11.88 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,090,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Mcgowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.